Parkinson Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Our findings highlight the importance of Pitx3-GDNF interplay in dopamine signaling and indicate that our strategy might be useful for the restoration of DAergic fate of NT2 cells to make them clinically applicable toward cell replacement therapy of PD.
|
31310388 |
2020 |
Parkinson Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Here we show that using transcription factor Pitx3 null mutant (Pitx3Null) mice as a model for severe and consistent DA denervation in the dorsal striatum in Parkinson's disease, antidromically identified striatonigral neurons (D1R-expressing dSPNs) had a lower baseline spike firing rate than that in DA-intact normal mice, and these neurons increased their spike firing more strongly in Pitx3Null mice than in WT mice in response to injection of L-dopa or the D1R agonist, SKF81297; the increase in spike firing temporally coincided with the motor-stimulating effects of L-dopa and SKF81297.
|
30104963 |
2018 |
Parkinson Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Pitx3 is expressed in mDA neuron subsets of the substantia nigra compacta (SNc) and of the ventral tegmental area (VTA) that are degeneration-sensitive in PD.
|
27514757 |
2017 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Here we examined adult hippocampal neurogenesis in the Pitx3-mutant mouse model of PD (<i>aphakia</i> mice), which phenotypically shows a selective embryonic degeneration of dopamine neurons within the SN and to a smaller extent in the ventral tegmental area (VTA).
|
28883785 |
2017 |
Parkinson Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Additionally, MK-801 treatment protected the dopaminergic (DAergic) neurons in the nigrostriatal pathway and improved motor functions by increasing the expression of Nurr-1 and Pitx-3 in the PD model.
|
27977132 |
2017 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Furthermore, the PITX3 C allele carriers with PD had a poorer cognitive performance in the visuospatial domain (p<0.001) and a higher incidence of visual hallucinations.
|
28991698 |
2017 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
The results of meta-analysis suggested that the PITX3 SNP rs3758549 was significantly associated with risk of PD in the Asian population (genotype TT+TC vs. CC, P=0.014; allele T vs. C, P=0.019) but not in the Caucasian population (genotype TT+TC vs. CC, P=0.053; allele T vs. C, P=0.251).
|
24394914 |
2014 |
Parkinson Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
PITX3 and risk for Parkinson's disease: a systematic review and meta-analysis.
|
24525476 |
2014 |
Parkinson Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Our results provide useful information that the NURR1 and PITX3 gene expression is decreased in the PBL of Chinese patients with PD, indicating their possible systemic involvement in PD.
|
22309633 |
2012 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Meta-analysis was carried out to evaluate whether PITX3 gene polymorphism was associated with PD, and subgroup analysis was also performed when necessary.
|
22429667 |
2012 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Previous finding suggesting three SNPs (rs2281983, rs4919621 and rs3758549) in the PITX3 gene to be associated with PD could not be replicated.
|
22411443 |
2012 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that these PITX3 SNPs do not contribute to the risk of developing PD in EOPD or LOPD in Chinese.
|
22037506 |
2011 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
These findings suggest that the PITX3 gene rs3758549 polymorphism may increase the susceptibility of PD.
|
21524731 |
2011 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Recent association studies indicated that three PITX3 single nucleotide polymorphisms (SNPs), including rs2281983, rs4919621, and rs3758549 are likely to be associated with PD.
|
21565251 |
2011 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Several polymorphisms of the Pitx3 gene have been linked with sporadic and early-onset forms of PD, but different studies have given conflicting or inconsistent findings.
|
21138504 |
2011 |
Parkinson Disease
|
0.300 |
Biomarker
|
disease |
BEFREE |
Our findings indicate that PITX3 may play a role in the pathogenesis of PD.
|
19394114 |
2011 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
Systematic genetic analysis of the PITX3 gene in patients with Parkinson disease.
|
21469209 |
2011 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
In particular, our highly significant findings regarding the association of rs3758549 reproduce the results of the initial report on transcription factor gene variants, providing further evidence for PITX3 and EN1 polymorphisms as potential genetic risk factors for sporadic PD.
|
19345444 |
2011 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
In contrast, a previous finding suggesting a SNP (rs3758549) in the putative promoter region of the PITX3 gene to be associated with PD could not be replicated.
|
18420308 |
2010 |
Parkinson Disease
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
No common PITX3 variants were associated with PD, although a rare missense change (G32S) was found in only one patient and none of the controls.
|
20468068 |
2010 |
Parkinson Disease
|
0.300 |
Biomarker
|
disease |
MGD |
Microphthalmia, parkinsonism, and enhanced nociception in Pitx3 ( 416insG ) mice.
|
20033184 |
2010 |
Parkinson Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
The role of transcription factor Pitx3 in dopamine neuron development and Parkinson's disease.
|
19754401 |
2009 |
Parkinson Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
An allele-dependent dysregulation of PITX3 expression might contribute to the susceptibility to PD.
|
17905480 |
2009 |
Parkinson Disease
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Such specific expression of the Pitx3 promoter may be used for gene therapy studies of Parkinson's disease.
|
18049867 |
2008 |
Parkinson Disease
|
0.300 |
Biomarker
|
disease |
MGD |
3,4-dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson's disease.
|
15728853 |
2005 |